FS120 Phase 1/1b Study in Patients With Advanced Malignancies
Clinical trial NCT04648202 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04648202
- Sponsor
- invoX Pharma Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2026-03-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.